| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/06/2007 | DE102006026026A1 Arzneimittel Drug |
| 12/06/2007 | CA2654270A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653288A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | CA2653077A1 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/06/2007 | CA2648987A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862166A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 12/05/2007 | EP1861387A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 12/05/2007 | EP1861083A1 Composition based on an avermectin and azelaic acid in particular for treating rosacea |
| 12/05/2007 | EP1485359B1 Sodium channel blockers |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1292278B1 Preparations that contain an extract of the plant pistia stratiotes |
| 12/05/2007 | EP1263752B1 Lpa receptor agonists and antagonists and methods of use |
| 12/05/2007 | EP1073418B1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 12/05/2007 | EP1006996B1 USE OF 17-$g(a)-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY |
| 12/05/2007 | CN101084000A External skin agent comprising modified clay for preventing inflammation |
| 12/05/2007 | CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents |
| 12/05/2007 | CN101081286A Chinese medicinal materials for skin whiting for removing freckle |
| 12/05/2007 | CN101081270A Medicine for treating foot helosis, callus and verrucosis |
| 12/05/2007 | CN101081267A Chinese medicinal material pill for beauty treatment |
| 12/05/2007 | CN101081258A Specific medicine for treating empyrosis |
| 12/05/2007 | CN101081255A kazukiyo oral liquid agent and its preparing process |
| 12/05/2007 | CN101081252A Chinese medicinal materials health products for treating eczema |
| 12/05/2007 | CN101081251A Polygonum multiflorum thunb processing method |
| 12/05/2007 | CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease |
| 12/05/2007 | CN101081237A Bag agent for hip bath for curing anal disease |
| 12/05/2007 | CN101081231A 痤疮软膏 Acne ointment |
| 12/05/2007 | CN101081224A Stable extended release oral dosage composition |
| 12/05/2007 | CN101081202A Skin-protection essential oil used in winter |
| 12/05/2007 | CN101081078A Lotus seed ginkgo nut beverage |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
| 12/05/2007 | CN100352832C Oligopeptides for promoting hair growing |
| 12/05/2007 | CN100352825C Extractive form active ingredient of bitter bamboo, prepartion method and application |
| 12/05/2007 | CN100352817C Pyridinoylpiperidines as 5-HTLF agonists |
| 12/05/2007 | CN100352809C Aminophenylbenzothiazole compounds |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
| 12/05/2007 | CN100352482C Medicine for treating burn and scald |
| 12/05/2007 | CN100352477C Wound healing medicine |
| 12/05/2007 | CN100352469C Externally applied medicine for treating burns and scalds |
| 12/05/2007 | CN100352466C Gynecologic antipruritic capsule, an dits prepn. method |
| 12/05/2007 | CN100352461C External-use medicine for treating leucoderma and its preparing method |
| 12/05/2007 | CN100352449C Medicament composition for treating tinea pedis and tinea corporis |
| 12/05/2007 | CN100352445C A method of treating human skin and a skin care composition for use in such a method |
| 12/05/2007 | CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 11/30/2007 | CA2591352A1 Treatment for herpes simplex virus and other infectious diseases |
| 11/29/2007 | WO2007137015A2 Dermatological uses of tri-, tetra-, penta-, and polypeptides |
| 11/29/2007 | WO2007136125A1 Compound having heterocyclic ring and use thereof |
| 11/29/2007 | WO2007136084A1 Agent for ameliorating the condition of sick building syndrome |
| 11/29/2007 | WO2007135941A1 Method for production of acetic acid bacterium-type ceramide |
| 11/29/2007 | WO2007135801A1 MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN |
| 11/29/2007 | WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy |
| 11/29/2007 | WO2007135132A1 Use of a composition consisting of a combination of hydroquinone, fluocinolone acetonide and tretinoin, intended for treatment signs of photoaging of the skin |
| 11/29/2007 | WO2007135027A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | WO2007112204A3 Ingestible compositions containing extracts |
| 11/29/2007 | WO2007093184B1 Treatment of mmp-mediated dermatological diseases with pemirolast |
| 11/29/2007 | WO2007078335A3 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 11/29/2007 | WO2007072233A3 Improved mimosa tenuiflora extracts, methods for its obtaining and use for the treatment of ulcers in mammals |
| 11/29/2007 | US20070276044 Peeling Cosmetic Method Using a 8-Hexadecene-1,16-Dicarboxylic Acid |
| 11/29/2007 | US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor |
| 11/29/2007 | US20070276039 Pharmaceutical uses for alpha2delta ligands |
| 11/29/2007 | US20070276019 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors |
| 11/29/2007 | US20070276004 Pharmaceutical Composition Comprising an Immunosuppressant for Use in the Treatment of Skin Diseases |
| 11/29/2007 | US20070275978 Of at Use of an Antagonist Compound of at Least One Receptor Selected From a Group Comprising Beta-Adrenergic Receptors, A at1, 5-Ht5 and Galanin Receptor for Preparing a Pharmaceutical Composition for Treating Rosacea |
| 11/29/2007 | US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine |
| 11/29/2007 | US20070275874 Use of Leptin in Wound Healing |
| 11/29/2007 | US20070275097 Cosmetic And/Or Dermatological Preparation And Use Thereof In The Regulation Of Skin Capillary Blood Flow |
| 11/29/2007 | US20070275093 Methods for Treating Non-Microbial Inflammatory Skin Conditioners |
| 11/29/2007 | US20070275084 Compositions And Methods For The Treatment Of Skin Damage |
| 11/29/2007 | US20070275045 Composition for the treatment of warts and molluscum contagiosum |
| 11/29/2007 | US20070275021 New cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same |
| 11/29/2007 | US20070275004 Group b streptococcus antigens |
| 11/29/2007 | US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 11/29/2007 | US20070274936 Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent |
| 11/29/2007 | DE20023915U1 Oxidativ stabile langkettige Ethylester-Weichmacher Oxidatively stable long-chain ethyl ester plasticizer |
| 11/29/2007 | DE102006024748A1 Proteasen-Inhibitor zur Wundbehandlung Protease inhibitor for the treatment of wounds |
| 11/29/2007 | CA2653117A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | CA2652432A1 .gamma.-l-pga producing microorganism, method of producing .gamma.-l-pga using the microorganism, crosslinked substance produced using the microorganism, and external dermal agentproduced using the microorganism |
| 11/29/2007 | CA2651487A1 Methods for treating chemotherapy and radiation therapy side effects |
| 11/29/2007 | CA2648946A1 Use of a composition consisting of a combination of hydroquinone, fluocinolone acetonide and tretinoin, intended for treatment signs of photoaging of the skin |
| 11/28/2007 | EP1860070A1 A particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 11/28/2007 | EP1859834A1 Anti-inflammatory agent |
| 11/28/2007 | EP1859806A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 11/28/2007 | EP1859796A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| 11/28/2007 | EP1859774A1 Hair cosmetic |
| 11/28/2007 | EP1858864A2 Stabilized compositions of volatile alkylating agents and methods of using thereof |